Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in Amyotrophic Lateral Sclerosis Gene Discovery
Samuel N. Smukowski, Heather Maioli, Caitlin S. Latimer, et al.
Neurology Genetics (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 24

Showing 24 citing articles:

Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
UNC13Ain amyotrophic lateral sclerosis: from genetic association to therapeutic target
Sean W. Willemse, Peter Harley, Ruben P.A. van Eijk, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 8, pp. 649-656
Open Access | Times Cited: 35
MRI biomarkers and neuropsychological assessments of hippocampal and parahippocampal regions affected by ALS: A systematic review
Sana Mohammadi, Sadegh Ghaderi, Farzad Fatehi
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 14
Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Randall J. Eck, Jade G. Stair, Brian C. Kraemer, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Assessment of risk of ALS conferred by the GGGGCC hexanucleotide repeat expansion in C9orf72 among first-degree relatives of patients with ALS carrying the repeat expansion
Iris F. Van Wijk, Ruben P.A. van Eijk, Loes van Boxmeer, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2023) Vol. 25, Iss. 1-2, pp. 188-196
Open Access | Times Cited: 12
Mitochondrial D-loop Methylation Levels Inversely Correlate with Disease Duration in Amyotrophic Lateral Sclerosis
Andrea Stoccoro, Adam R. Smith, Lorena Mosca, et al.
Epigenomics (2024) Vol. 16, Iss. 4, pp. 203-214
Closed Access | Times Cited: 4
Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities
Angie K. Torres, Rodrigo G. Mira, Cristina Pinto, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models
Rong-Mei Xu, Qiaoju Kang, Xuefei Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3030-3030
Open Access
Early-onset, conjugal, twin-discordant, and clusters of sporadic ALS: Pathway to discovery of etiology via lifetime exposome research
Peter S. Spencer, Valerie S. Palmer, Glen E. Kisby, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Eva Bagyinszky, John Hulme, Seong Soo A. An
Cells (2023) Vol. 12, Iss. 15, pp. 1948-1948
Open Access | Times Cited: 7
Advancements and challenges in amyotrophic lateral sclerosis
David Bradford, Kathleen E. Rodgers
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Enhancing Robotic-Assisted Lower Limb Rehabilitation Using Augmented Reality and Serious Gaming
Cãlin Vaida, Gabriela Rus, Paul Tucan, et al.
Applied Sciences (2024) Vol. 14, Iss. 24, pp. 12029-12029
Open Access | Times Cited: 2
A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis
Rupesh Kumar, Md. Zubbair Malik, Thangavel Alphonse Thanaraj, et al.
Cellular Signalling (2023) Vol. 112, pp. 110915-110915
Open Access | Times Cited: 6
In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis
Toluwase Hezekiah Fatoki, Stanley Chukwuejim, Chibuike C. Udenigwe, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5828-5828
Open Access | Times Cited: 4
The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology
Valentina La Cognata, Giovanna Morello, Maria Guarnaccia, et al.
Progress in Neurobiology (2024) Vol. 235, pp. 102587-102587
Open Access | Times Cited: 1
Exploring the impact of circular RNA on ALS progression: A systematic review
Santhiya Panchalingam, K. Govindaraju
Brain Research (2024) Vol. 1838, pp. 148990-148990
Closed Access | Times Cited: 1
Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
Abdul Aziz Mohamed Yusoff, Siti Zulaikha Nashwa Mohd Khair
Reviews in the Neurosciences (2024)
Open Access | Times Cited: 1
Genetic landscape of ALS in Malta based on a quinquennial analysis
Maia Farrugia Wismayer, Andrew Farrugia Wismayer, Rebecca Borg, et al.
Neurobiology of Aging (2022) Vol. 123, pp. 200-207
Open Access | Times Cited: 7
A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis
Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1884-1884
Open Access | Times Cited: 3
Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS
Christina Vasilopoulou, Sarah L. McDaid-McCloskey, Gavin McCluskey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4021-4021
Open Access | Times Cited: 2
Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis
Joshua James Crose, Arezou Crose, John Ransom, et al.
Neurodegenerative Disease Management (2024) Vol. 14, Iss. 3-4, pp. 111-117
Closed Access
Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis
Debolina D. Biswas, Ronit Sethi, Yochebed Woldeyohannes, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access
Decreased Hsp90 activity protects against TDP-43 neurotoxicity in a C. elegans model of amyotrophic lateral sclerosis
Laura García‐Toscano, Heather N. Currey, Joshua C. Hincks, et al.
PLoS Genetics (2024) Vol. 20, Iss. 12, pp. e1011518-e1011518
Open Access
New Mission, New Reviews, New Word Counts, Oh My!
Stefan M. Pulst
Neurology Genetics (2022) Vol. 8, Iss. 6
Open Access | Times Cited: 1
Page 1

Scroll to top